◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Sai Life Sciences Limited (SAILIFE)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-09-20
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.
关键数据
- 市值: ₹340 billion
- 收入（截至 2026-03-31 财年）: ₹21.4B
- 净利润: ₹3.5B
- 毛利率: 39.4%
- 净利率: 16.3%
查看交互式图表与完整报表 →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| 总收入 | ₹21.4B | ₹16.6B | ₹14.6B | ₹12.0B |
| 毛利 | ₹8.4B | ₹6.2B | ₹4.9B | ₹3.2B |
| 营业利润（EBIT） | ₹4.7B | ₹2.7B | ₹1.8B | ₹768M |
| 净利 | ₹3.5B | ₹1.7B | ₹828M | ₹100M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 SAILIFE 交互式查看器。 /companies/us/SAILIFE
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.